12:00 AM
 | 
Sep 24, 2012
 |  BC Week In Review  |  Company News  |  Deals

Merck KGaA, Kyoto University deal

Merck's EMD Millipore Corp. division received a non-exclusive, worldwide license to develop and commercialize an induced pluripotent stem (iPS) cell patent...

Read the full 93 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >